EMA 9/21 crossover, 4h, 95% of equity (vol-targeting study: baseline) · BNBUSDT 4h: +2,194.70%

EMA 9/21 crossover, 4h, 95% of equity (vol-targeting study: baseline) · BNBUSDT 4h: +2,194.70% — Janorium backtest